Background and aims Central and Eastern Europe (CEE) is a largely understudied region,
despite having the highest cardiovascular disease mortality in Europe. This analysis aimed …

Background—Cardiovascular disease has become the leading cause of death in China. We
examined the levels of serum total and lipoprotein cholesterol and status of awareness …

Background Little is known about the achievement of low density lipoprotein cholesterol
(LDL-C) targets in patients at cardiovascular risk receiving stable lipid-lowering therapy …

Importance Atherosclerotic cardiovascular disease (ASCVD) is highly prevalent in the US,
with studies indicating substantial rates of nonadherence to and undertreatment with statin …

Importance In patients with atherosclerotic cardiovascular disease (ASCVD), guidelines
recommend optimizing statin treatment, and consensus pathways suggest use of ezetimibe …

PURPOSE Statins reduce the risk of mortality and coronary artery disease in individuals at
high cardiovascular risk. Using nationally representative data, we examined the …

Introduction Hypertriglyceridemia is associated with increased atherosclerotic
cardiovascular disease (ASCVD) event risk, which persists even in statin-treated patients …

Background and aims Lipid-modifying agents (LMAs) are increasingly used to reduce lipid
levels and prevent cardiovascular events but the magnitude of their consumption in different …

Background This study aimed to investigate the prevalence and status of dyslipidemia
management among South Korean adults, as performed by the Korean Society of Lipid and …

Aims To provide contemporary data on the implementation of European guideline
recommendations for lipid-lowering therapies (LLTs) across different settings and …